Ovaban Tab 20mg 20 mg Tablet is a Health Canada–registered veterinary drug (DIN 00460818) held by Schering-Plough Canada Inc, containing Megestrol Acetate. Health Canada lists its status as Cancelled Post Market (status date 04 Aug 2009). Nexara Health has matched 129 registrations of Megestrol Acetate across 26 other regulated markets, 1 of them in the same strength and dosage form.
Health Canada registration
| DIN | 00460818 |
|---|---|
| Brand name | Ovaban Tab 20mg |
| Active ingredient | Megestrol Acetate |
| Strength | 20 mg |
| Dosage form | Tablet |
| Route | Oral |
| Company | Schering-Plough Canada Inc |
| Status | Cancelled Post Market — 04 Aug 2009 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Megestrol Acetate registered in other markets
129 registrations of the same molecule in 26 national registries outside Canada (first 87 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Finland | Megestrol Vet | Orion Corporation Orion Pharma | 20 mg | tabletti | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Croatia | Megace | Bausch Health Ireland Limited | tbl. 30x160 mg | RS | HZZO | |
| Croatia | Megostat | Bausch Health Ireland Limited | susp. za oral. primj. 1x240 ml (40 mg/ml) | RS | HZZO | |
| Czech Republic | Megace | — | 160MG | Tbl Nob | R | SUKL DLP |
| Czech Republic | Megace | — | 40MG/ML | Por Sus | R | SUKL DLP |
| Czech Republic | Megaplex | — | 160MG | Tbl Nob | R | SUKL DLP |
| Denmark | Megace | Orifarm A/S | 160 mg | tabletter | Par-Imp | Laegemiddelstyrelsen |
| Dominican Republic | Megace | Bristol Myers Squibb Holding Pharma De Puerto Rico | Registered | MISPAS | ||
| Finland | Megace | Bristol-Myers Squibb Ab | 160 mg | tabletti | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Megeron | Neofarma | 5 mg | tabletti | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Megestin | Oy Leiras Finland Ab | 10 mg | tabletti | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Megestrol Vet | Orion Corporation Orion Pharma | 5 mg | tabletti | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Niagestin | Novo | 15 mg | tabletti | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Niagestin | Novo | 60 mg | tabletti | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Greece | MEGACE TABLET 160MG/TAB BT x 30(σε blisters) | Bausch Health Ireland Limited, Ireland | reimbursed | MoH deltio timwn | ||
| Hong Kong | Apo-Megestrol Tab 40mg | Hind Wing Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Megaplex Tab 160mg | Teva Pharmaceutical Hong Kong O/B Teva Pharmaceutical Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Megaplex Tab 40mg | Teva Pharmaceutical Hong Kong O/B Teva Pharmaceutical Hong Kong Limited | Registered | DH Drug Office | ||
| Hong Kong | Megejohn Tablets 40mg | Synmosa Biopharma (Hong Kong) Company Limited | Registered | DH Drug Office | ||
| Hong Kong | Megesia Tablets 40mg | Sb Pharma Limited | Registered | DH Drug Office | ||
| Hong Kong | Megesin Tab 160mg | Teva Pharmaceutical Hong Kong O/B Teva Pharmaceutical Hong Kong Limited | Registered | DH Drug Office | ||
| Hungary | Cachexi 40 mg/mL Belsőleges Szuszpenzió | HCM Pharma Korlátolt Felelősségű Társaság | 1x240ml hdpe tartályban 30 ml-es pp adagolópohárral | NEAK PUPHA | ||
| Hungary | Megace Belsőleges Szuszpenzió | Bausch Health Ireland Limited | 1x240ml flakonban | NEAK PUPHA | ||
| Hungary | Megesin 160 mg Tabletta | Teva Nederland B.V. | 100x üvegben | NEAK PUPHA | ||
| Hungary | Megestrol Acetate Oral Suspension 625 mg/5 mL | HealthCare Med Kereskedelmi és Szolgáltató Korlátolt Felelősségű Társaság | 150 ml | NEAK PUPHA | ||
| Hungary | Megestrol Pharmacenter 160 mg Tabletta | Pharmacenter Europe Korlátolt Felelősségű Társaság | 100x buborékcsomagolásban pvc/al | NEAK PUPHA | ||
| Hungary | Megyrina 40 mg/mL Belsőleges Szuszpenzió | Vipharm Spolka Akcyjna | 1x240ml hdpe tartályban | NEAK PUPHA | ||
| Iceland | Megace | Parlogis - óskráð lyf | 160 mg | töflur | 0 | Lyfjastofnun lyfjaverdskra |
| Ireland | Megace 160 mg tablets | Bausch Health Ireland Limited | Tablet | Marketed | HPRA | |
| Ireland | Megace 160 mg tablets | PCO Manufacturing Ltd. | Tablet | Unknown | HPRA | |
| Ireland | Megace 160 mg Tablets | IMED Healthcare Ltd. | Tablet | Unknown | HPRA | |
| Ireland | Megace 40 mg/ml oral suspension | Originalis B.V. | Oral suspension | Unknown | HPRA | |
| Ireland | Megace 40 mg/ml oral suspension | PCO Manufacturing Ltd. | Oral suspension | Unknown | HPRA | |
| Ireland | Megace 40 mg/ml Oral Suspension | IMED Healthcare Ltd., | Oral suspension | Unknown | HPRA | |
| Ireland | Megace 40 mg/ml Oral Suspension | Bausch Health Ireland Limited | Oral suspension | Marketed | HPRA | |
| Luxembourg | MEGACE CPR. 160 mg 1*30 CPR. | — | RR | CNS liste positive | ||
| Malaysia | Apo-Megestrol 160mg | Pharmaforte (Malaysia) Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | hovid-Megestrol Oral Suspension 40mg/ml | Hovid Berhad | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Megex-I Suspension 800mg/20ml | Imeks Pharma Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Mexico | Megestrol | — | Grupo Nº 23: Cuidados paliativos | CSG Compendio (formulary) | ||
| Mexico | Megestrol | — | Grupo Nº 23: Cuidados paliativos | CSG Compendio (formulary) | ||
| Netherlands | Megestrolacetaat 160 mg Focus, tabletten | Focus Care Pharmaceuticals B.V. | Tablet | Uitsluitend recept | EU national register | |
| Netherlands | Megestrolacetaat Teva 160 mg, tabletten | Teva Nederland B.V. | Tablet | Uitsluitend recept | EU national register | |
| Norway | Megace tab 160 mg | Bausch Health Companies Inc. | 30 | Tablett | Aktiv oppføring | FEST (DMP) |
| Norway | Megace tab 160 mg | Bausch Health Ireland Limited | 30 | Tablett | Aktiv oppføring | FEST (DMP) |
| Poland | Cachexan | Polfarmex S.A. | 40 mg/ml | Zawiesina doustna | Bezterminowe | URPL RPL |
| Poland | Megace | Bausch Health Ireland Ltd. | 40 mg/ml | Zawiesina doustna | Bezterminowe | URPL RPL |
| Poland | Megalia | Vipharm S.A. | 40 mg/ml | Zawiesina doustna | Bezterminowe | URPL RPL |
| Poland | Megastril | Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A. | 40 mg/ml | Zawiesina doustna | Bezterminowe | URPL RPL |
| Romania | MEGESIN 160 mg | — | 160mg | Compr. | PR | ANMDMR nomenclator |
| Romania | MEGESIN 160 mg | — | 160mg | Compr. | PR | ANMDMR nomenclator |
| Saudi Arabia | Megace | — | 20 | Inactive | SFDA | |
| Saudi Arabia | Megace | — | 40 | Inactive | SFDA | |
| Serbia | Megace® | Pharmaswiss D.o.o., Beograd | OBNOVA | ALIMS | ||
| Serbia | Megace® | Pharmaswiss D.o.o., Beograd | OBNOVA | ALIMS | ||
| Serbia | Megoxi® | Pharmaswiss D.o.o., Beograd | OBNOVA | ALIMS | ||
| Singapore | APO-MEGESTROL TABLET 160 mg | Pharmaforte Singapore Pte Ltd | 160 mg | Tablet | Prescription Only | HSA |
| Singapore | APO-MEGESTROL TABLET 40 mg | Pharmaforte Singapore Pte Ltd | 40 mg | Tablet | Prescription Only | HSA |
| Slovakia | MEGESIN 160 mg | Tev-Nl-4 | tbl 100x160 mg | 1G | MZ SR kategorizacia | |
| Slovenia | Megace 160 mg tbl. 30x | — | P* | CBZ | ||
| Slovenia | Megace 40 mg/ml peroral.susp. 240 ml | — | P* | CBZ | ||
| Taiwan | Effidel Oral Suspension 40mg/ml | 晟德大藥廠股份有限公司新竹廠 | 懸液劑 | Registered | TFDA | |
| Taiwan | Giga Oral Suspension 40mg/ml | 溫士頓醫藥股份有限公司 | 懸液劑 | Registered | TFDA | |
| Taiwan | Megace 160mg Tablet | Bristol Arzneimittel Niederlassung Troisdorf Dor Bristol-Myers Squibb GmbH | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Megace Oral Suspension 40mg/mL | Contract Pharmaceuticals Limited Niagara | 懸液劑 | 已註銷 | TFDA | |
| Taiwan | Megace Tablets | Bristol-Myers Squibb Laboratories Company | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Megace Tablets 160mg "Australia" | Bristol-Myers Squibb Australia Pty. Ltd. | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Megace Tablets 40mg | Bristol-Myers Squibb U.s. Pharmaceutical Group | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Megaplex Tablets 160mg | Pharmachemie B.v. | 錠劑 | 已註銷 | TFDA | |
| Turkey | Borea 160 mg 30 Tablet | Onko İlaç San. Ve Ti̇c. A.ş. | Aktif | TITCK | ||
| Turkey | Megace 160 mg 30 Tablet | Deva Holdi̇ng A.ş. | Aktif | TITCK | ||
| United Kingdom | Megestrol 10mg/5ml oral suspension | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Megestrol 160mg tablets | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Megestrol 160mg/5ml oral suspension | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Megestrol 200mg/5ml oral suspension | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Megestrol 20mg capsules | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Megestrol 20mg/5ml oral suspension | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Megestrol 40mg tablets | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Megestrol 40mg/5ml oral suspension | — | 0001 | NHS dm+d VMP | ||
| United States | megestrol acetate | Zhejiang Xianju Pharmaceutical Co., Ltd. | Powder | FDA NDC | ||
| United States | Megestrol Acetate | Xttrium Laboratories, Inc. | Suspension | listed | FDA NDC | |
| United States | Megestrol Acetate | PAI Holdings, LLC dba PAI Pharma | Suspension | listed | FDA NDC | |
| United States | Megestrol Acetate | PAI Holdings, LLC dba PAI Pharma | Suspension | listed | FDA NDC | |
| United States | Megestrol Acetate | Teva Pharmaceuticals USA, Inc. | Tablet | listed | FDA NDC | |
| United States | Megestrol Acetate | Teva Pharmaceuticals USA, Inc. | Tablet | listed | FDA NDC | |
| United States | Megestrol Acetate | Major Pharmaceuticals | Tablet | listed | FDA NDC | |
| United States | Megestrol Acetate | Major Pharmaceuticals | Suspension | listed | FDA NDC |
See every manufacturer of Megestrol Acetate worldwide →
Regulator price references for Megestrol Acetate
Published list or reimbursement prices for Megestrol Acetate presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Greece | MEGACE TABLET 160MG/TAB BT x 30(σε blisters) | 160mg | 30.78 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Hungary | Megace Belsőleges Szuszpenzió | 240ml | 1x240ml flakonban | 12,516.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Megyrina 40 mg/mL Belsőleges Szuszpenzió | 240ml | 1x240ml hdpe tartályban | 12,516.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Cachexi 40 mg/mL Belsőleges Szuszpenzió | 240ml+30ml | 1x240ml hdpe tartályban 30 ml-es pp adagolópohárral | 12,516.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Megesin 160 mg Tabletta | 160mg | 100x üvegben | 21,493.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Megestrol Pharmacenter 160 mg Tabletta | 160mg | 100x buborékcsomagolásban pvc/al | 21,493.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Megestrol Acetate Oral Suspension 625 mg/5 mL | 150ml | 150 ml | 35,500.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Iceland | Megace | 160mg | pakki | 6,638.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Luxembourg | MEGACE CPR. 160 mg 1*30 CPR. | 160mg | 41.95 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Norway | Megace | 160mg | 30 stk | 396.80 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Saudi Arabia | Megace | 81.15 SAR | public | SFDA | 2026-09-01 | ||
| Saudi Arabia | Megace | 140.60 SAR | public | SFDA | 2026-09-01 | ||
| Slovakia | MEGESIN 160 mg | 160mg | tbl 100x160 mg | 68.43 EUR | categorised final price | MZ SR kategorizacia | 2026-09-02 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Ovaban Tab 20mg (DIN 00460818) marketed in Canada?
No. Health Canada lists DIN 00460818 as Cancelled Post Market as of 04 Aug 2009.
Who holds the Canadian licence for this product?
Schering-Plough Canada Inc is the company of record in the Health Canada Drug Product Database.
Is Megestrol Acetate registered outside Canada?
Yes — Nexara Health has matched 129 registrations in 26 other markets, including 1 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00460818, status date 2009-08-04; national medicine registries: ALIMS, ANMDMR nomenclator, CBZ, CNS liste positive, CSG Compendio (formulary), DH Drug Office, EU national register, FDA NDC, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MISPAS, MoH deltio timwn, MZ SR kategorizacia, NEAK PUPHA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MZ SR kategorizacia, NEAK PUPHA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00460818, status date 2009-08-04; national medicine registries: ALIMS, ANMDMR nomenclator, CBZ, CNS liste positive, CSG Compendio (formulary), DH Drug Office, EU national register, FDA NDC, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MISPAS, MoH deltio timwn, MZ SR kategorizacia, NEAK PUPHA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MZ SR kategorizacia, NEAK PUPHA, SFDA.
Health Canada Drug Product Database (DPD), DIN 00460818, status date 2009-08-04; national medicine registries: ALIMS, ANMDMR nomenclator, CBZ, CNS liste positive, CSG Compendio (formulary), DH Drug Office, EU national register, FDA NDC, FEST (DMP), Fimea Perusrekisteri, HPRA, HSA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MISPAS, MoH deltio timwn, MZ SR kategorizacia, NEAK PUPHA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: CNS liste positive, DMP (Statens legemiddelverk) maksimalpris, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MZ SR kategorizacia, NEAK PUPHA, SFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.